Equities
Health CareMedical Equipment and Services
  • Price (USD)396.74
  • Today's Change1.11 / 0.28%
  • Shares traded1.20m
  • 1 Year change+17.90%
  • Beta0.9222
Data delayed at least 15 minutes, as of Jul 01 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

  • Revenue in USD (TTM)23.22bn
  • Net income in USD2.86bn
  • Incorporated1946
  • Employees53.00k
  • Location
    Stryker Corp1941 STRYKER WAYPORTAGE 49002United StatesUSA
  • Phone+1 (269) 385-2600
  • Fax+1 (269) 385-1062
  • Websitehttps://www.stryker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SYK:NYQ since
announced
Transaction
value
Inari Medical IncDeal completed06 Jan 202506 Jan 2025Deal completed9.74%4.89bn
NICO CorpDeal completed20 Sep 202420 Sep 2024Deal completed8.68%--
Vertos Medical IncAnnounced22 Aug 202422 Aug 2024Announced14.89%--
care.ai IncDeal completed12 Aug 202412 Aug 2024Deal completed21.02%--
MOLLI Surgical IncDeal completed31 Jul 202431 Jul 2024Deal completed20.14%--
Data delayed at least 15 minutes, as of Jul 01 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medtronic PLC33.54bn4.66bn111.69bn95.00k24.102.3314.793.333.623.6226.0137.460.36922.175.31353,021.105.164.555.955.1565.3966.2513.9913.071.4211.190.371484.203.623.0126.82-0.27238.915.33
Danaher Corp23.82bn3.77bn141.37bn61.00k38.302.7823.095.945.165.1632.6271.060.29313.706.92390,491.804.635.915.096.5459.8059.4015.8119.381.0515.550.244714.68-0.06285.92-7.1710.5316.989.40
Stryker Corp23.22bn2.86bn151.20bn53.00k53.397.2238.566.517.417.4160.1754.780.54371.626.25438,075.506.696.648.117.9464.5763.8312.3113.020.9985--0.44544.0110.238.71-5.437.523.079.27
Thermo Fisher Scientific Inc42.90bn6.52bn153.06bn125.00k23.793.1015.993.5717.0417.04112.23130.840.43744.864.47343,184.006.737.687.819.0241.3444.2415.3816.641.3824.800.40867.090.051310.925.6711.338.6215.48
Boston Scientific Corp17.55bn2.03bn158.91bn53.00k78.737.1547.929.051.361.3611.7915.020.45712.027.03331,188.705.273.086.103.5768.7368.5111.547.780.88349.840.3350.0017.619.3018.0325.385.31--
Intuitive Surgical Inc8.71bn2.48bn194.77bn15.64k79.7011.3964.3822.356.826.8224.0147.730.49732.017.42557,289.9014.2312.3115.6113.7167.0967.3028.6226.113.97--0.000.0017.2413.2729.1810.9821.16--
Data as of Jul 01 2025. Currency figures normalised to Stryker Corp's reporting currency: US Dollar USD

Institutional shareholders

33.38%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202531.43m8.24%
Greenleaf Asset Management, Inc.as of 08 May 202517.98m4.71%
BlackRock Fund Advisorsas of 31 Mar 202516.59m4.35%
SSgA Funds Management, Inc.as of 31 Mar 202514.81m3.88%
T. Rowe Price Associates, Inc. (IM)as of 31 Mar 202511.62m3.05%
Geode Capital Management LLCas of 31 Mar 20257.31m1.92%
JPMorgan Investment Management, Inc.as of 31 Mar 20257.31m1.92%
Capital Research & Management Co. (Global Investors)as of 31 Mar 20256.86m1.80%
Fundsmith LLPas of 31 Mar 20256.86m1.80%
Fidelity Management & Research Co. LLCas of 31 Mar 20256.57m1.72%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.